The Janssen Pharmaceutical Companies of Johnson & Johnson on March 5, 2019, announced the U.S. Food and Drug Administration (FDA) has approved SPRAVATO® (esketamine) CIII nasal spray for use in conjunction with an oral antidepressant in adults with treatment-resistant depression (TRD).
https://tinyurl.com/y2har9qm
On Saturday 12/15/18, we are excited to attend and participate in Chicago’s arm of the National Mental Health Community Symposium. The Symposium aims to connect communities to resources for mental health services. We feel privileged to exhibit alongside the incredible organizations that serve the Chicago community. We hope to see you there!
https://www.nmhcsymposium.com/
We are pleased to announce that Dr. Yuhwen Chow has joined our team as an investigator. Dr. Chow is board certified in psychiatry and brings over 15 years of experience to CRC. We are thrilled to have her as part of the team.
The Chicago Research Center team had the privilege of participating in one of Tourette Camp USA’s registration events this past Sunday on April 29th. The 25th Annual Tourette Camp USA will run from June 24th-June 30th at YMCA Camp Duncan in Ingleside, Illinois. At Sunday’s event, our own Dr. Plyler presented about the promising new studies and options for the treatment of Tourette Syndrome. Our team felt honored to meet and engage with the inspirational organizers of the camp and the participating families and children affected by the condition.
The Chicago Research Center is pleased to announce that Dr. Barry Levy has joined our team of clinical trial investigators. Dr. Levy is board certified in neurology, sleep medicine, and formerly neurophysiology.
A graduate of John Hopkins University and the Maryland School of medicine, Dr. Levy has been in clinical practice for over 30 years and practicing sleep medicine for over 20 years both in private practice and with the Center for Sleep Medicine. Dr. Levy brings his expertise and enthusiasm to the Chicago Research Center Team.
The Tourette Syndrome Camp Organization (TSCO) will host the 25th annual Tourette Syndrome Camp USA from June 24th – June 30th at YMCA Camp Duncan in Ingleside, Illinois. Chicago Research Center is excited to announce that our team will be presenting at the event!
For more information about the camp, visit https://www.tourettecampusa.com/register-summer-2018/
To learn more about our current pediatric Tourette trial, visit https://www.chicagoresearchcenter.com/tourette/
Thank you to all who attended our inaugural lunch and learn! Attendees were able to hear about groundbreaking therapies in the area of mental health. Keep an eye out for additional programs like this as the year progresses!
As we reach another milestone of 15 years, we are pleased with the impact we continue to make. Please take a moment to read the impact we’ve recently made:
“This was one of the best things I have done I my entire life. The study in which I was involved was interesting and worthwhile. The staff (every one of them) were, not only highly professional but, most importantly, extremely personable. From the moment I walked in on Day 1 till the day the study ended 20 weeks later, I felt part of the family–I felt as if I belonged. It was actually sad for the study to have ended. I have, however, been assured that something else will come up and I am already so looking forward to it. The facility is super clean, super comfortable and very homey. Thank you to everyone who was so kind to me.”
– Susanne, participant
Chicago Research Center is proud to have worked on and contributed to the scientific knowledge of a myriad of pharmaceutical and bio-medical products over the past 15 years. We continue to strive to provide quality data and ensure the safety and quality treatment of our volunteer subjects.
Here are some of the FDA approved treatments for which we have had the pleasure to contribute to:
